Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Welcure Drugs And Pharmaceuticals Limited
Welcure Drugs And Pharmaceuticals Limited, with incorporation dating back to 1996, brings more than 3 decades of expertise. Corporate ID: L24232DL1996PLC227773, registered with number 227773. It falls under the category of company limited by shares. The firm’s authorized share capital totals ₹116.00 crore. Welcure Drugs And Pharmaceuticals Limited reports paid-up capital of ₹112.44 crore.
Its primary business activity involves manufacture of chemicals and chemical products. It is registered in Delhi. Welcure Drugs And Pharmaceuticals Limited is incorporated at Plot No. 55, Office No. 104, First Floor, Vijay Block, Laxmi Nagar, East Delhi , Delhi, East Delhi, New Delhi, New Delhi, Delhi, India, 110092. The company is currently active. For correspondence, the registered email address is welcuredrugs227@gmail.com. The senior leadership includes Altaf Hussain Shah (CFO).
Company Overview
- CIN
- Date of Incorporation
- 06/08/1996
- Company Status
- Active
- RoC
- Delhi
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹1,16,00,00,000.00
- Paid up Capital
- ₹1,12,43,51,500.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- welcuredrugs227@gmail.com
- PAN
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| IN8331C01024 | WELCURE DRUGS AND PHARMACEUTICALS LIMITED EQ NEW FV RE. 1/-LISTING/TRADG APRVL AWAITED | - | 12/10/2026 | WELCURE DRUGS/SH VTG | ESVUFN |
| INE331C01025 | WELCURE DRUGS AND PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | - | 12/10/2026 | WELCURE DRUGS/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹1.11L | ₹3.03L | ₹2.09L | ₹5.68L | ₹0.00L |
| Inventory | ₹14,352.36L | ₹14,352.36L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Debt | ₹0.00L | ₹12,319.89L | ₹0.00L | ₹0.00L | ₹0.00L |
| Common Stock | ₹12,359.40L | ₹11,243.91L | ₹1,343.91L | ₹1,343.91L | ₹0.00L |
| Share Issued | ₹12,359.40L | ₹1,125.12L | ₹135.12L | ₹135.12L | ₹0.00L |
| Total Assets | ₹51,018.95L | ₹26,697.82L | ₹137.10L | ₹152.89L | ₹0.00L |
| Capital Stock | ₹12,359.40L | ₹11,243.91L | ₹1,343.91L | ₹1,343.91L | ₹0.00L |
| Long Term Debt | ₹0.00L | ₹12,319.89L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Assets | ₹35,754.94L | ₹18,214.11L | ₹3.18L | ₹0.59L | ₹0.00L |
| Working Capital | -₹5,561.96L | ₹14,087.23L | ₹0.12L | -₹0.77L | ₹0.00L |
| Invested Capital | ₹9,702.03L | ₹22,570.94L | ₹134.05L | ₹151.53L | ₹0.00L |
| Common Stock Equity | ₹9,702.03L | ₹10,251.05L | ₹134.05L | ₹151.53L | ₹0.00L |
| Net Tangible Assets | ₹9,702.03L | ₹10,251.05L | ₹134.05L | ₹151.53L | ₹0.00L |
| Tangible Book Value | ₹9,702.03L | ₹10,251.05L | ₹134.05L | ₹151.53L | ₹0.00L |
| Current Liabilities | ₹41,316.90L | ₹4,126.88L | ₹3.06L | ₹1.36L | ₹0.00L |
| Stockholders Equity | ₹9,702.03L | ₹10,251.05L | ₹134.05L | ₹151.53L | ₹0.00L |
| Other Equity Interest | -₹2,657.37L | -₹992.86L | -₹1,209.87L | ₹0.00L | -₹1,202.56L |
| Total Capitalization | ₹9,702.03L | ₹22,570.94L | ₹134.05L | ₹151.53L | ₹0.00L |
| Ordinary Shares Number | ₹12,359.40L | ₹1,125.12L | ₹135.12L | ₹135.12L | ₹0.00L |
| Other Non Current Assets | ₹8.02L | ₹7.73L | ₹0.01L | ₹0.00L | ₹3.08L |
| Total Non Current Assets | ₹15,264.00L | ₹8,483.72L | ₹133.91L | ₹152.30L | ₹0.00L |
| Cash And Cash Equivalents | ₹57.62L | ₹12.83L | ₹2.16L | ₹0.12L | ₹0.00L |
| Other Non Current Liabilities | ₹0.02L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹9,702.03L | ₹10,251.05L | ₹134.05L | ₹151.53L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹41,316.92L | ₹16,446.77L | ₹3.05L | ₹1.36L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹0.00L | ₹12,319.89L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹57.62L | ₹12.82L | ₹2.16L | ₹0.12L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹0.02L | ₹12,319.89L | -₹0.01L | ₹0.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Free Cash Flow | ₹173.53L | -₹22,204.58L | -₹12.76L | ₹10.69L | ₹0.00L |
| Changes In Cash | ₹44.79L | ₹10.66L | ₹2.03L | -₹6.48L | ₹0.00L |
| End Cash Position | ₹57.62L | ₹12.83L | ₹2.16L | ₹0.12L | ₹0.00L |
| Financing Cash Flow | ₹0.00L | ₹22,219.89L | -₹1.71L | -₹17.17L | ₹0.00L |
| Investing Cash Flow | -₹128.74L | -₹6.35L | ₹16.50L | ₹0.00L | ₹0.00L |
| Operating Cash Flow | ₹173.53L | -₹22,202.88L | -₹12.76L | ₹10.69L | ₹0.00L |
| Beginning Cash Position | ₹12.83L | ₹2.16L | ₹0.12L | ₹6.60L | ₹0.00L |
| Issuance Of Capital Stock | ₹0.00L | ₹9,900.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | -₹549.01L | ₹278.01L | -₹26.38L | ₹10.17L | ₹0.00L |
| EBITDA | -₹547.10L | ₹278.77L | -₹22.79L | ₹10.49L | ₹0.00L |
| Net Income | -₹549.01L | ₹217.01L | -₹17.48L | ₹10.17L | ₹0.00L |
| Gross Profit | ₹4,317.12L | ₹404.66L | ₹0.00L | ₹0.00L | ₹0.00L |
| Pretax Income | -₹549.01L | ₹278.01L | -₹17.48L | ₹10.17L | ₹0.00L |
| Tax Provision | ₹0.00L | ₹61.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹36,553.83L | ₹2,455.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cost Of Revenue | ₹32,236.71L | ₹2,050.34L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Expenses | ₹37,249.27L | ₹2,367.98L | ₹26.38L | ₹13.54L | ₹0.00L |
| Interest Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Income | -₹695.44L | ₹87.02L | -₹26.38L | -₹13.54L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | -₹547.10L | ₹278.77L | -₹22.47L | -₹8.78L | ₹0.00L |
| Normalized Income | -₹549.01L | ₹217.01L | -₹17.16L | -₹9.10L | ₹0.00L |
| Operating Expense | ₹5,012.56L | ₹317.64L | ₹26.38L | ₹13.54L | ₹0.00L |
| Operating Revenue | ₹36,553.83L | ₹2,455.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Interest Income | ₹0.00L | ₹0.00L | ₹0.00L | ₹4.43L | ₹0.00L |
| Other Operating Expenses | ₹5,000.29L | ₹289.23L | ₹6.54L | ₹6.06L | ₹0.00L |
| Reconciled Depreciation | ₹1.91L | ₹0.76L | ₹3.59L | ₹0.32L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹32,236.71L | ₹2,050.34L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income Common Stockholders | -₹549.01L | ₹217.01L | -₹17.48L | ₹10.17L | ₹0.00L |
| Net Income Continuous Operations | -₹549.01L | ₹217.01L | -₹17.48L | ₹10.17L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | -₹549.01L | ₹217.01L | -₹17.48L | ₹10.17L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Non Operating Interest Income Expense | ₹0.00L | ₹0.00L | ₹5.78L | ₹4.43L | ₹0.00L |
| Net Income Including Noncontrolling Interests | -₹549.01L | ₹217.01L | -₹17.48L | ₹10.17L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | -₹549.01L | ₹217.01L | -₹17.48L | ₹10.17L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | -₹549.01L | ₹217.01L | -₹17.48L | ₹10.17L | ₹0.00L |
Company Performance (FY25–FY26)
₹365.5 Cr₹274.2 Cr₹182.8 Cr₹91.4 Cr₹0
FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 22/10/2022 | Manowar Ali | *****8323P | Company Secretary | |
| 14/11/2023 | Altaf Hussain Shah | 10351528 | Managing Director | View other directorships |
| 14/11/2023 | Suraj Chagan Solanki | 10380845 | Director | View other directorships |
| 14/02/2024 | Deepika Krishnan Iyer | 10515778 | Director | View other directorships |
| 14/02/2024 | Altaf Hussain Shah | *****3074E | CFO | |
| 04/10/2024 | Pradeep Dnyaneshwar Terse | 10758084 | Additional Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 6
- Altaf Hussain ShahManaging Director
- Deepika Krishnan IyerDirector
- Suraj Chagan SolankiDirector
- Pradeep Dnyaneshwar TerseAdditional Director
- Altaf Hussain ShahCFO
- Manowar AliCompany Secretary
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 09/12/2024 | Form AOC-4(XBRL)-29102024 | - |
| 27/11/2024 | Form MGT-7-27112024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Plot No. 55, Office No. 104, First Floor, Vijay Block, Laxmi Nagar, East Delhi , Delhi, East Delhi, New Delhi, New Delhi, Delhi, India, 110092
Frequently Asked Questions
What is the incorporation date of Welcure Drugs And Pharmaceuticals Limited?
The incorporation date of Welcure Drugs And Pharmaceuticals Limited is 06/08/1996.
What is the authorized share capital and paid-up capital of Welcure Drugs And Pharmaceuticals Limited?
The authorized share capital of Welcure Drugs And Pharmaceuticals Limited is ₹1,16,00,00,000.00. The paid-up capital is ₹1,12,43,51,500.00.
Who are the current board members & directors of Welcure Drugs And Pharmaceuticals Limited?
The current board member of Welcure Drugs And Pharmaceuticals Limited are:
- Altaf Hussain Shah
- Suraj Chagan Solanki
- Pradeep Dnyaneshwar Terse
- Deepika Krishnan Iyer
What is the registered address of Welcure Drugs And Pharmaceuticals Limited?
The registered address of Welcure Drugs And Pharmaceuticals Limited is Plot No. 55, Office No. 104, First Floor, Vijay Block, Laxmi Nagar, East Delhi , Delhi, East Delhi, New Delhi, New Delhi, Delhi, India, 110092.
What is the Corporate Identification Number of Welcure Drugs And Pharmaceuticals Limited?
The Corporate Identification Number of Welcure Drugs And Pharmaceuticals Limited is L24232DL1996PLC227773.